173 related articles for article (PubMed ID: 31669650)
1. GLUT-1 participates in the promotion of LncRNA CASC9 in proliferation and metastasis of laryngeal carcinoma cells.
Xi J; Wang Y; Liu H
Gene; 2020 Feb; 726():144194. PubMed ID: 31669650
[TBL] [Abstract][Full Text] [Related]
2. Silencing SOX2 Expression by RNA Interference Inhibits Proliferation, Invasion and Metastasis, and Induces Apoptosis through MAP4K4/JNK Signaling Pathway in Human Laryngeal Cancer TU212 Cells.
Yang N; Wang Y; Hui L; Li X; Jiang X
J Histochem Cytochem; 2015 Sep; 63(9):721-33. PubMed ID: 26001828
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of lncRNA CASC9 promotes esophageal squamous cell carcinoma growth by negatively regulating PDCD4 expression through EZH2.
Wu Y; Hu L; Liang Y; Li J; Wang K; Chen X; Meng H; Guan X; Yang K; Bai Y
Mol Cancer; 2017 Aug; 16(1):150. PubMed ID: 28854977
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of long non-coding RNA SNHG1 contributes to proliferation and metastasis in laryngeal squamous cell carcinoma.
Lin SX; Jiang H; Xiang GZ; Zhang WR; Weng YH; Qiu FD; Wu J; Wang HG
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1333-1341. PubMed ID: 29565491
[TBL] [Abstract][Full Text] [Related]
5. LncRNA CASC9 interacts with CPSF3 to regulate TGF-β signaling in colorectal cancer.
Luo K; Geng J; Zhang Q; Xu Y; Zhou X; Huang Z; Shi KQ; Pan C; Wu J
J Exp Clin Cancer Res; 2019 Jun; 38(1):249. PubMed ID: 31186036
[TBL] [Abstract][Full Text] [Related]
6. The Expression of the Long Noncoding RNA AFAP1-AS1 in Laryngeal Carcinoma Affects the Proliferation, Invasion, Migration, and Apoptosis of TU212 Cell Line.
Chen X; Hu Z; Bing L; Zhu X; Liu K; Liu Y; Liu J
Biomed Res Int; 2022; 2022():2337447. PubMed ID: 35968243
[TBL] [Abstract][Full Text] [Related]
7. In vivo evaluation of the effects of simultaneous inhibition of GLUT-1 and HIF-1α by antisense oligodeoxynucleotides on the radiosensitivity of laryngeal carcinoma using micro 18F-FDG PET/CT.
Shen LF; Zhao X; Zhou SH; Lu ZJ; Zhao K; Fan J; Zhou ML
Oncotarget; 2017 May; 8(21):34709-34726. PubMed ID: 28410229
[TBL] [Abstract][Full Text] [Related]
8. Blocking long noncoding RNA MALAT1 restrained the development of laryngeal and hypopharyngeal carcinoma.
Xu E; Liang X; Ji Z; Zhao S; Li L; Lang J
Eur Arch Otorhinolaryngol; 2020 Feb; 277(2):611-621. PubMed ID: 31792655
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma.
Sassenberg M; Droop J; Schulz WA; Dietrich D; Loick SM; Wiek C; Scheckenbach K; Gaisa NT; Hoffmann MJ
BMC Cancer; 2019 Aug; 19(1):806. PubMed ID: 31412811
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of lncRNA FTH1P3 predicts a poor prognosis and promotes aggressive phenotypes of laryngeal squamous cell carcinoma.
Yuan H; Jiang H; Wang Y; Dong Y
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31142627
[TBL] [Abstract][Full Text] [Related]
11. Silence of cancer susceptibility candidate 9 inhibits gastric cancer and reverses chemoresistance.
Shang C; Sun L; Zhang J; Zhao B; Chen X; Xu H; Huang B
Oncotarget; 2017 Feb; 8(9):15393-15398. PubMed ID: 28146436
[TBL] [Abstract][Full Text] [Related]
12. Glucose transporter-1 expression in CD133+ laryngeal carcinoma Hep-2 cells.
Chen XH; Bao YY; Zhou SH; Wang QY; Wei Y; Fan J
Mol Med Rep; 2013 Dec; 8(6):1695-700. PubMed ID: 24146103
[TBL] [Abstract][Full Text] [Related]
13. LncRNA CASC9 Suppressed the Apoptosis of Gastric Cancer Cells through Regulating BMI1.
Fang J; Chen W; Meng XL
Pathol Oncol Res; 2020 Jan; 26(1):475-482. PubMed ID: 31642035
[TBL] [Abstract][Full Text] [Related]
14. LncRNACASC9 promotes proliferation, metastasis, and cell cycle inovarian carcinoma cells through cyclinG1/TP53/MMP7 signaling.
Sun M; Chen Y; Liu X; Cui Y
Bioengineered; 2021 Dec; 12(1):8006-8019. PubMed ID: 34595994
[TBL] [Abstract][Full Text] [Related]
15. LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway.
Ding S; Qu W; Jiao Y; Zhang J; Zhang C; Dang S
Cancer Biomark; 2018; 22(2):217-226. PubMed ID: 29630517
[TBL] [Abstract][Full Text] [Related]
16. The long noncoding RNA CASC9 regulates migration and invasion in esophageal cancer.
Pan Z; Mao W; Bao Y; Zhang M; Su X; Xu X
Cancer Med; 2016 Sep; 5(9):2442-7. PubMed ID: 27431358
[TBL] [Abstract][Full Text] [Related]
17. lncRNA CASC9 positively regulates CHK1 to promote breast cancer cell proliferation and survival through sponging the miR‑195/497 cluster.
Shao G; Wang M; Fan X; Zhong L; Wang Z; Zhang P; Ji S
Int J Oncol; 2019 May; 54(5):1665-1675. PubMed ID: 30816435
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA CASC9.5 promotes the proliferation and metastasis of lung adenocarcinoma.
Zhou J; Xiao H; Yang X; Tian H; Xu Z; Zhong Y; Ma L; Zhang W; Qiao G; Liang J
Sci Rep; 2018 Jan; 8(1):37. PubMed ID: 29311567
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of miR-129-5p affects laryngeal cancer cell proliferation, invasiveness, and migration by affecting STAT3 expression.
Shen N; Huang X; Li J
Tumour Biol; 2016 Feb; 37(2):1789-96. PubMed ID: 26318305
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of long non-coding RNA RP11-297P16.3 inhibits the migration and invasion of laryngeal squamous carcinoma cells.
Wu H; Wang W; Zhu J
Clin Transl Oncol; 2021 Oct; 23(10):2057-2065. PubMed ID: 33893613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
